Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital's Stephen Dunn
Article By:
The Life Sciences Report
Monday, February 23, 2015 3:42 PM EDT
Immuno-oncology took center stage in the drug development world in 2014. But can this preeminence continue in 2015? In this interview, Stephen Dunn of LifeTech Capital outlines how companies are leveraging these therapies, and where investors should look for opportunity in the sector.
In this article: MRK, BMY, RHHBY, ESRX, PFE, MKGAY, AZN, KITE, JUNO, NVS, DNDN, JNJ, AMGN, XON, ZIOP, CBMG
Dendreon Files For Bankruptcy, Stock Tanks
Article By:
Terry Chrisomalis
Monday, November 10, 2014 6:47 PM EDT
Dendreon files for Chapter 11 bankruptcy after disappointing sales for Provenge
Frontrunning: June 10
Article By:
Tyler Durden
Tuesday, June 10, 2014 9:05 AM EDT
Ukraine, Russia Fail to Reach Deal in Natural-Gas Talks (WSJ). Boko Haram Kidnaps More Girls in Nigeria (WSJ). Déjà vu: echoes of pre-crisis world mount (FT)...
In this article: ALEX, ALU, AMD, BLT, CCE, CL, CS, CVX, DEO, DUK, GM, MRK, TOT, TSN, TWC, WMT, XOM, DNDN, IDIX, BEAV, EBAY, META